These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25511806)

  • 1. Topical Lyogel Containing Corticosteroid Decreases IgE Expression and Enhances the Therapeutic Efficacy Against Atopic Eczema.
    Ng SF; Anuwi NA; Tengku-Ahmad TN
    AAPS PharmSciTech; 2015 Jun; 16(3):656-63. PubMed ID: 25511806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay.
    Kircik LH
    J Drugs Dermatol; 2014 May; 13(5):582-5. PubMed ID: 24809882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential treatment of atopic dermatitis: tolerability and safety of cream containing nanoparticles loaded with hydrocortisone and hydroxytyrosol in human subjects.
    Siddique MI; Katas H; Jamil A; Mohd Amin MCI; Ng SF; Zulfakar MH; Nadeem SM
    Drug Deliv Transl Res; 2019 Apr; 9(2):469-481. PubMed ID: 29159691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trial.
    Mandelin J; Remitz A; Virtanen H; Reitamo S
    Acta Derm Venereol; 2010 Mar; 90(2):170-4. PubMed ID: 20169301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice.
    Yamamoto M; Haruna T; Yasui K; Takahashi H; Iduhara M; Takaki S; Deguchi M; Arimura A
    Allergol Int; 2007 Jun; 56(2):139-48. PubMed ID: 17460441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrocortisone butyrate 0.1% cream (proprietary lipid rich cream vehicle) does not significantly suppress hypothalamic-pituitary-adrenal axis and is effective in pediatric patients 3 months and older with extensive atopic dermatitis.
    Abramovits W; Oquendo M
    Skinmed; 2010; 8(3):150-4. PubMed ID: 21137620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-allergic effects of Vernonia amygdalina leaf extracts in hapten-induced atopic dermatitis-like disease in mice.
    Ngatu NR; Okajima MK; Yokogawa M; Hirota R; Takaishi M; Eitoku M; Muzembo BA; Sabah AB; Saruta T; Miyamura M; Kaneko T; Sano S; Suganuma N
    Allergol Int; 2012 Dec; 61(4):597-607. PubMed ID: 22918214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the leaf gel extracts of Aloe ferox and Aloe vera in the topical treatment of atopic dermatitis in Balb/c mice.
    Finberg MJ; Muntingh GL; van Rensburg CE
    Inflammopharmacology; 2015 Dec; 23(6):337-41. PubMed ID: 26510768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is new in atopic dermatitis/eczema?
    Plötz SG; Wiesender M; Todorova A; Ring J
    Expert Opin Emerg Drugs; 2014 Dec; 19(4):441-58. PubMed ID: 25286776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
    Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three randomised phase I/IIa trials of 5% cis-urocanic acid emulsion cream in healthy adult subjects and in patients with atopic dermatitis.
    Peltonen JM; Pylkkänen L; Jansén CT; Volanen I; Lehtinen T; Laihia JK; Leino L
    Acta Derm Venereol; 2014 Jul; 94(4):415-20. PubMed ID: 24284985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proof of efficacy of Kamillosan(R) cream in atopic eczema.
    Patzelt-Wenczler R; Ponce-Pöschl E
    Eur J Med Res; 2000 Apr; 5(4):171-5. PubMed ID: 10799352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vivo dermal pharmacokinetics, efficacy, and safety of skin targeting nanoparticles for corticosteroid treatment of atopic dermatitis.
    Siddique MI; Katas H; Amin MC; Ng SF; Zulfakar MH; Jamil A
    Int J Pharm; 2016 Jun; 507(1-2):72-82. PubMed ID: 27154252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency.
    Aubert-Wastiaux H; Moret L; Le Rhun A; Fontenoy AM; Nguyen JM; Leux C; Misery L; Young P; Chastaing M; Danou N; Lombrail P; Boralevi F; Lacour JP; Mazereeuw-Hautier J; Stalder JF; Barbarot S
    Br J Dermatol; 2011 Oct; 165(4):808-14. PubMed ID: 21671892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Constitutional eczema; the possibilities of local treatment].
    Sillevis Smitt JH
    Ned Tijdschr Geneeskd; 2002 Mar; 146(9):400-4. PubMed ID: 11901940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled polymeric nanoparticles for percutaneous co-delivery of hydrocortisone/hydroxytyrosol: an ex vivo and in vivo study using an NC/Nga mouse model.
    Hussain Z; Katas H; Mohd Amin MC; Kumolosasi E; Buang F; Sahudin S
    Int J Pharm; 2013 Feb; 444(1-2):109-19. PubMed ID: 23337632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A murine model of epicutaneous protein sensitization is useful to study efficacies of topical drugs in atopic dermatitis.
    Lehto M; Savinko T; Wolff H; Kvist PH; Kemp K; Lauerma A; Alenius H
    Int Immunopharmacol; 2010 Apr; 10(4):377-84. PubMed ID: 20074670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of adrenal suppression of a lipid enhanced, topical emollient cream formulation of hydrocortisone butyrate 0.1% in treating children with atopic dermatitis.
    Eichenfield L; Ellis CN; Fivenson D; Hebert AA; Dromgoole S; Piacquadio D
    Pediatr Dermatol; 2007; 24(1):81-4. PubMed ID: 17300659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a hydrogel containing bisabolol-loaded nanocapsules for the treatment of atopic dermatitis in a Balb/c mice model.
    Karami H; Niavand MR; Haddadi R; Noriyan A; Vafaei SY
    Int J Pharm; 2024 May; 656():124029. PubMed ID: 38527566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.